170 related articles for article (PubMed ID: 30279174)
1. Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples.
Pepe F; De Luca C; Smeraglio R; Pisapia P; Sgariglia R; Nacchio M; Russo M; Serra N; Rocco D; Battiloro C; Ambrosio F; Gragnano G; Vigliar E; Bellevicine C; Troncone G; Malapelle U
J Clin Pathol; 2019 Jan; 72(1):38-45. PubMed ID: 30279174
[TBL] [Abstract][Full Text] [Related]
2. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
[TBL] [Abstract][Full Text] [Related]
3. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
[TBL] [Abstract][Full Text] [Related]
4. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract][Full Text] [Related]
5. Cell free DNA analysis by SiRe
Pisapia P; Pepe F; Smeraglio R; Russo M; Rocco D; Sgariglia R; Nacchio M; De Luca C; Vigliar E; Bellevicine C; Troncone G; Malapelle U
J Thorac Dis; 2017 Oct; 9(Suppl 13):S1383-S1390. PubMed ID: 29184677
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
7. Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel.
Malapelle U; Pepe F; Pisapia P; Sgariglia R; Nacchio M; De Luca C; Lacalamita R; Tommasi S; Pinto R; Palomba G; Palmieri G; Vacirca D; Barberis M; Bottillo I; Grammatico P; Grillo LR; Costa V; Smeraglio R; Bruzzese D; Troncone G
Front Oncol; 2020; 10():236. PubMed ID: 32219061
[No Abstract] [Full Text] [Related]
8. Tumor mutational burden on cytological samples: A pilot study.
Pepe F; Pisapia P; Gristina V; Rocco D; Micheli M; Micheli P; Iaccarino A; Tufano R; Gragnano G; Russo G; De Luca C; Sgariglia R; Nacchio M; Girolami I; Eccher A; Russo A; Troncone G; Malapelle U
Cancer Cytopathol; 2021 Jun; 129(6):460-467. PubMed ID: 33378102
[TBL] [Abstract][Full Text] [Related]
9. Idylla
Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a fast and fully automated platform to diagnose
Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
[TBL] [Abstract][Full Text] [Related]
11. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
12. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
[TBL] [Abstract][Full Text] [Related]
13. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
14. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study.
Bessi S; Pepe F; Russo G; Pisapia P; Ottaviantonio M; Biancalani F; Iaccarino A; Russo M; Biancalani M; Troncone G; Malapelle U
J Clin Pathol; 2023 Mar; 76(3):206-210. PubMed ID: 35701144
[TBL] [Abstract][Full Text] [Related]
16. Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Deeb KK; Hohman CM; Risch NF; Metzger DJ; Starostik P
Arch Pathol Lab Med; 2015 Jul; 139(7):913-21. PubMed ID: 26125431
[TBL] [Abstract][Full Text] [Related]
17. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
Xu X; Yang Y; Li H; Chen Z; Jiang G; Fei K
Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
[TBL] [Abstract][Full Text] [Related]
19. Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huang H; Springborn S; Haug K; Bartow K; Samra H; Menon S; Mackinnon AC
J Mol Diagn; 2019 Sep; 21(5):862-872. PubMed ID: 31443844
[TBL] [Abstract][Full Text] [Related]
20. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J
Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]